Jiang Ning | Biological Nanoparticles | Women Researcher Award

Dr. Jiang Ning, Chongqing Medical University, China .

Dr. Jiang Ning is an Associate Professor at Chongqing Medical University’s Department of Pathology. He earned his Bachelor’s and Master’s in Clinical Medicine, followed by a Doctorate in Basic Medicine from the same institution. With a strong research background, Dr. Ning has contributed significantly to advancing pathology, especially in areas like tumor biology, photodynamic therapy, and tumor-targeted drug delivery. His work has led to numerous high-impact publications in leading medical journals. Dr. Ning is dedicated to bridging clinical pathology with innovative research to improve patient care and therapeutic outcomes .

Publication profile

Orcid

Education and Experience

Education

2008-2013: Bachelor of Clinical Medicine, Chongqing Medical University
2013-2016: Master’s in Clinical Medicine, Chongqing Medical University
2016-2019: Doctorate in Basic Medicine, Chongqing Medical University

Job Experience

2019-2021: Doctor & Lecturer, Department of Pathology, Chongqing Medical University
2021-Present: Associate Professor, Department of Pathology, Chongqing Medical University

Suitability For The Award

Dr. Jiang Ning is an exemplary candidate for the Women Researcher Award, recognized for her outstanding contributions to medical research, particularly in the areas of tumor biology, cancer therapy, and bioinformatics. As an Associate Professor at Chongqing Medical University, she has made significant strides in advancing cancer research, with a focus on developing innovative therapeutic strategies and bioinformatics tools to address complex clinical challenges. Her work not only demonstrates exceptional scientific acumen but also highlights her leadership in research and her dedication to improving patient outcomes through groundbreaking medical discoveries.

Professional Development

Dr. Jiang Ning is a leading researcher and educator specializing in pathology, with a keen focus on tumor biology, molecular mechanisms of tumor development, and innovative therapeutic approaches. His work has made substantial contributions to bioinformatics sequencing, high-throughput functional genomics, and the development of tumor-targeted therapies. As a project leader in multiple significant research initiatives, Dr. Ning has enhanced the understanding of hepatobiliary and pancreatic tumors, paving the way for drug target identification and the development of novel treatments. His continued involvement in advancing clinical pathology and drug delivery systems is transforming patient care.

Research Focus

Dr. Jiang Ning’s research centers on tumor biology and the molecular mechanisms underlying the development of hepatobiliary and pancreatic cancers. His research spans high-throughput functional genomics, proteomics, and metabolomics to identify clinical diagnostic and prognostic markers. A significant aspect of his work is focused on new tumor therapies, such as photothermal/photodynamic treatments, and the use of biological nanoparticles for drug delivery. His investigations aim to enhance targeted drug delivery and assess drug resistance using electrochemistry and spectroscopy, with the goal of advancing personalized medicine and improving clinical outcomes .

Publications Top Notes

Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape – Biomedicines, 2023, (Cited by: 49)
E3 Ubiquitin Ligase FBXO3 Drives Neuroinflammation to Aggravate Cerebral Ischemia/Reperfusion Injury – International Journal of Molecular Sciences, 2022, (Cited by: 20)